SANOFI-AVENTIS RECHERCHE & DEVELOPPEMENT - France 

This institution has been merged with: SANOFIAVENTIS.

Ranking results:

Past rankings:

2018
Criterium:Position:
Overall Score:900-1000
Total Number of Projects:400-500
Networking Rank (Reputation):> 1000
2016
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
2012
Criterium:Position:
Overall Score:900-1000
Total Project Funding per Partner:> 1000
Total Number of Projects:70
Total Project Funding:> 1000
Networking Rank (Reputation):> 1000
Networking Rank (Reputation):> 1000
Partner Constancy:46
Project Leadership Index:75
Diversity Index:60
2011
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):800-900

Ranking timeline:

Project Participation Performance(2011-01-01 - 2025-12-31 ):

Total Project Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

Total number of projects: 13
As coordinator: 0
As participant: 13
Sole participant: 0
Coordinator / Participant Ratio: 0*

*Ratio includes only projects with > 2 partners

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2017 0 36.861.590 412.423 5
2016 0 20.650.631 0 3
2013 0 8.197.401 985.539 2
2012 0 8.000.000 616.154 1
2011 0 15.625.805 1.097.986 2
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:

Institution:Projects [No]:
F HOFFMANNLA ROCHE5
JANSSEN PHARMACEUTICA NV5
CHARITE UNIVERSITAETSMEDIZIN BERLIN4
ELI LILLY AND COMPANY LIMITED4
ASTRAZENECA AB3
BOEHRINGER INGELHEIM PHARMA GMBH &CO KG3
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE3
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE3
NOVARTIS PHARMA3
ORION OYJ3
PFIZER LIMITED3
UNIVERSITY COLLEGE LONDON3
UPPSALA UNIVERSITET3
ABBVIE DEUTSCHLAND GMBH & CO KG2
ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE2
EIDGENOESSISCHE TECHNISCHE HOCHSCHULE ZUERICH2
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM2
EUROPEAN CANCER PATIENT COALITION2
EUROPEAN MOLECULAR BIOLOGY LABORATORY2
GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT2
INSTITUT DE RECHERCHES INTERNATIONALES SERVIER2
INSTITUT PASTEUR2
KAROLINSKA INSTITUTE2
KATHOLIEKE UNIVERSITEIT LEUVEN2
KING'S COLLEGE LONDON2
MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN2
MERCK SHARP & DOHME CORP2
QUEEN MARY AND WESTFIELD COLLEGE UNIVERSITY OF LONDON2
THE CHANCELLOR MASTERS AND SCHOLARSOF THE UNIVERSITY OF CAMBRIDGE2
THE UNIVERSITY OF LIVERPOOL2
UCB BIOPHARMA2
UNIVERSITA DEGLI STUDI DEL PIEMONTE ORIENTALE AMEDEO AVOGADRO2
UNIVERSITAT WIEN2
UNIVERSITE CATHOLIQUE DE LOUVAIN2
UNIVERSITY OF OSLO2
A N BAKH INSTITUTE OF BIOCHEMISTRY OF THE RUSSIAN ACADEMY OF SCIENCES1
ABBVIE1
ABBVIE INC1
ACTELION PHARMACEUTICALS1
ADVANCELL ADVANCED IN VITRO CELL TECHNOLOGIES1
ALERE TECHNOLOGIES1
ALTIUS INSTITUTE FOR BIOMEDICAL SCIENCES1
AMGEN1
AMGEN LIMITED1
ARLENDA1
ARTTIC1
ASOCIACION NACIONAL EMPRESARIAL DE LA INDUSTRIA FARMACEUTICA1
ASSISTANCE PUBLIQUE HOPITAUX DE PARIS1
ASTELLAS PHARMA EUROPE BV1
ASTRAZENECA INDIA PVT1
AXXAM1
BAYER AKTIENGESELLSCHAFT1
BAYER PHARMA1
BIOCOMPUTING PLATFORMS LTD OY1
BIOEMISSION TECHNOLOGY SOLUTIONS IKE1
CAMBRIDGE INNOVATION TECHNOLOGIES CONSULTING LIMITED1
CELGENE MANAGEMENT SARL1
CELLWORKS RESEARCH INDIA PRIVATE LIMITED1
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE1
CENTRO DE NEUROCIENCIAS E BIOLOGIACELULAR ASSOCIACAO1
CERMAKOVA IVA1
CERTARA UK LIMITED1
COLLABORATIVE DRUG DISCOVERY INC CORPORATION1
COMMISSARIAT A L'ENERGIE ATOMIQUE1
CONCENTRIS RESEARCH MANAGEMENT1
CONSIGLIO NAZIONALE DELLE RICERCHE1
CONSORCI INSTITUT D'INVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYER1
CRANFIELD UNIVERSITY1
CSL BEHRING1
DEUTSCHES ZENTRUM FUR NEURODEGENERATIVE ERKRANKUNGEN EV1
EBERHARD KARLS UNIVERSITAET TUEBINGEN1
EISAI LIMITED1
ELVESYS SAS1
ERASMUS UNIVERSITEIT ROTTERDAM1
EUROPEAN PATIENTS' FORUM1
FEDERAAL KENNISCENTRUM VOOR DE GEZONDHEIDSZORG1
FEDERATION EUROPEENNE D'ASSOCIATIONS ET D'INDUSTRIES PHARMACEUTIQUES1
FIN CERAMICA FAENZA1
FOLKEHELSEINSTITUTTET1
FORSCHUNGSGESELLSCHAFT FUR ARBEITSPHYSIOLOGIE UND ARBEITSSCHUTZ E V1
FORSCHUNGSZENTRUM JULICH1
FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E V1
FUNDACIO D'INVESTIGACIO SANITARIA DE LES ILLES BALEARS RAMON LLULL1
FUNDACIO INSTITUT DE RECERCA BIOMEDICA1
FUNDACIO INSTITUT MAR D INVESTIGACIONS MEDIQUES IMIM1
GOETEBORGS UNIVERSITET1
H LUNDBECK AS1
HEALTH IQ LIMITED1
IHE INSTITUTET FOR HALSO OCH SJUKVARDSEKONOMI AKTIEBOLAG1
IN1
INDIAN INSTITUTE OF SCIENCE1
INSTITUT DE RECHERCHES SERVIER1
INSTITUTO TUMORI ""GIOVANNI PAOLO II""1
INTEGRATED TECHNOLOGIES LIMITED1
INTERNATIONAL ALLIANCE OF PATIENT'ORGANIZATIONS1
INTERSYSTEMS1
ISTITUTO EUROPEO DI ONCOLOGIA1
JOHN INNES CENTRE1
KLINIKUM RECHTS DER ISAR DER TECHNISCHEN UNIVERSITAT MUNCHEN1
KUNGLIGA TEKNISKA HOEGSKOLAN1

Constancy:

Total number of partners: 248
Partner loyalty:
Frequent Partner: (> 2 projects): 45
Rare Partner: 203
Frequent / Rare Partner Ratio: 0.22

Project overview:

Start dateProjectacronymrolefundingpartners
2017-10-01European Quality In Preclinical Data EQIPDparticipant4.495.52330
2017-02-01Cardio Ultraefficient nanoParticles for Inhalation of Drug prOducts CUPIDOparticipant6.094.78113
2017-02-01Big Data for Better Outcomes, Policy Innovation and Healthcare System Transformation - Sofia ref.: 116055 DO-ITparticipant3.549.83336
2017-01-01Multiple manifestations of genetic and non-genetic factors in Multiple Sclerosis disentangled with a multi-omics approach to accelerate personalised medicine MultipleMSparticipant14.721.45322
2017-01-01Translational quantitative systems toxicology to improve the understanding of the safety of medicines - Sofia: 116030 TransQSTparticipant8.000.00023
2016-11-01Inflammation and AD: modulating microglia function focussing on TREM2 and CD33 - Sofia ref.: 115976 PHAGOparticipant8.838.00020
2016-10-01Patient Preferences in benefit risk assessments during the drug life cycle - Sofia ref.: 115966 PREFERparticipant6.000.00033
2016-01-01Imaging the Force of Cancer FORCEparticipant5.812.63116
2013-10-01Label Free Particle Sorting LAPASOparticipant4.228.4188
2013-01-01Infection biology training network: shaping the future of infectious diseases treatments INBIONETparticipant3.968.98310
2012-05-01New Oral Nanomedicines: Transporting Therapeutic Macromolecules across the Intestinal Barrier TRANS-INTparticipant8.000.00017
2011-11-01Novel nanoparticles for drug delivery to the skin NANODRUGparticipant3.752.7538
2011-02-01More Medicines for Tuberculosis MM4TBparticipant11.873.05225